No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial - ScienceDirect
Frontiers | Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer
Overview of serum and tissue markers in colorectal cancer: a primer for radiologists | Abdominal Radiology
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
Sensitivity of CEA and TPA-M in patients with colorectal cancer... | Download Table
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer
Biochemical Markers of Colorectal Cancer – Present and Future | CMAR
Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer | Semantic Scholar
Colon cancer stage and tumor marker levels | Download Table
Tumor Marker:- Part 11 - Carcinoembryonic Antigen (CEA) - Labpedia.net
Do Frequent Follow-Up Tests Help Colorectal Cancer Survivors? - NCI
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
What is a cancer marker test? | Vinmec
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Introduction of Cancer Markers – Laboratory Services & Consultations Limited
CEA concentration in supernatant of different colon cancer cell lines | Download Table
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/425728fadcea61776ea78a6e3ecbd2698e2a1f5d/4-Table3-1.png "PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar")
PDF] Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? | Semantic Scholar
